A joint bid to lead the Chinese Nationalist Party (KMT) by media personality and Broadcasting Corp of China chairman Jaw Shaw-kong (趙少康) and former Kaohsiung mayor Han Kuo-yu (韓國瑜) would receive the highest support among KMT supporters, a survey conducted by the pan-green camp showed yesterday.
Jaw on Monday announced that he had applied to restore his KMT membership and that he did not rule out entering the race for party chairperson.
KMT Chairman Johnny Chiang (江啟臣) on Wednesday said that Jaw’s request to return to the KMT has been approved and that Jaw would be appointed to the party’s Central Advisory Committee after the Lunar New Year holiday.
Photo: Lu Hsin-te, Taipei Times
The survey showed that while the general public preferred former New Taipei City mayor Eric Chu (朱立倫) as KMT chairman, polling of KMT members showed their preference for Jaw.
However, if Han were to enter the race, but not Jaw, KMT supporters showed a preference for Chu, giving him a lead of 4.3 percentage points over Han, it showed.
If the general public were to choose between Chu, Jaw, Chiang and Sean Lien (連勝文), a former Taipei mayoral candidate and son of former vice president Lien Chan (連戰), they also preferred Chu, with Chu leading at 41 percent and all other candidates following at less than 20 percent, including Jaw at 18 percent, it showed.
However, self-identified KMT supporters, when asked the same question, gave Jaw the lead at 41.9 percent, followed by Chu at 34.9 percent and Han at 29 percent, the survey showed.
Han’s move to bring back Jaw might be a winning strategy to seize power in the KMT, as this could marginalize Chiang and Lien, pundits said.
However, the survey also showed lower backing for Jaw and Han among younger KMT supporters, those under 40 years old.
Pundits said that the return of Jaw, 70, would not rejuvenate the KMT, although he was once considered the party’s “golden boy" before he left in 1993 to found the New Party.
While the antiparasitic drug ivermectin is being touted as a treatment for COVID-19 in many parts of the world, Taiwanese experts on Monday warned against regular use of the drug in COVID-19 treatment, citing a lack of solid evidence. “Following an experts’ meeting, we do not recommend regular use of ivermectin in treating COVID-19 due to the lack of enough evidence,” said Chang Shan-chwen (張上淳), convener of the Central Epidemic Command Center’s (CECC) expert advisory panel. A report in the American Journal of Therapeutics said that meta-analyses based on 18 randomized controlled treatment trials of ivermectin in COVID-19 patients had found large,
CLASSES HALTED: Cram schools have had to return tuition fees due to mandatory closures and might need to lay off half of their staff because of a lack of revenue The COVID-19 pandemic has taken a toll on the education sector, with some cram schools and tutoring centers saying they might soon be unable to pay their instructors due to the extension of a nationwide level 3 COVID-19 alert. The heightened alert level means schools must remain closed, so cram schools and tutoring centers have had to return tuition fees, one cram school said. June is normally the peak season for recruiting new students at cram schools and tutoring centers, but this year many such schools might need to lay off half of their staff due to a lack of
A person who was on Friday reported as the first in Taiwan to die after receiving a COVID-19 vaccine died of a heart attack, a Central Epidemic Command Center (CECC) official said yesterday. The deceased, whose sex and age were not disclosed, had coronary artery disease, which led to a fatal heart attack, Centers for Disease Control Deputy Director-General Chuang Jen-hsiang (莊人祥), who is the CECC’s spokesman, told a news conference, citing the autopsy report. It was the first death listed as a possible adverse event after receiving the AstraZenenca COVID-19 vaccine since the start of the vaccination program on March 22. The
PARTY LINES: Just 28.1% of respondents said they were willing to get a local vaccine, including 52.8% of DPP voters and 48.6% of Taiwan Statebuilding Party voters Sixty-two percent of Taiwanese disapprove of the Central Epidemic Command Center’s (CECC) progress in obtaining COVID-19 vaccines, while 65.6 percent said that they would not take domestic vaccines that lack WHO certification, a poll released yesterday by Trend Survey and Research and commissioned by the Taiwan People’s Party (TPP) found. Trend Survey general manager Wu Shih-chang (吳世昌) announced the results of the survey with TPP officials at a virtual news conference, adding that 41.3 percent of respondents said that they highly disapproved of the center’s efforts to secure vaccines. About 68.6 percent of the respondents agreed that the country should rely on